| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
27,289,000 | 27,289,000 | 27,256,000 | 27,072,000 | 28,091,000 |
| Cost of Revenue
|
-15,832,000 | -15,832,000 | -15,113,000 | -14,748,000 | -15,212,000 |
|
Gross Profit
|
11,456,000 | 11,456,000 | 12,142,000 | 12,324,000 | 12,878,000 |
| Selling, General and Administrative Expenses
|
-3,640,000 | -3,640,000 | -3,541,000 | -3,406,000 | -3,172,000 |
|
Research and Development Expenses
|
-930,000 | -930,000 | -870,000 | -1,001,000 | -1,045,000 |
| Other Income/Expense, Operating
|
-5,702,000 | -5,702,000 | -5,386,000 | -5,233,000 | -4,992,000 |
|
Operating Income/Expenses
|
-10,272,000 | -10,272,000 | -9,797,000 | -9,640,000 | -9,209,000 |
|
Total Operating Profit/Loss
|
1,184,000 | 1,184,000 | 2,345,000 | 2,684,000 | 3,669,000 |
| Total Net Finance Income/Expense
|
55,000 | 55,000 | 61,000 | 33,000 | -11,000 |
| Net Investment Income
|
123,000 | 123,000 | 33,000 | 370,000 | 72,000 |
|
Rental Income
|
56,000 | 56,000 | 47,000 | 43,000 | 42,000 |
| Irregular Income/Expenses
|
-581,000 | -581,000 | -167,000 | -450,000 | -5,000 |
|
Other Income/Expense, Non-Operating
|
2,415,000 | 2,415,000 | 27,000 | -32,000 | 56,000 |
|
Non-Operating Income/Expenses, Total
|
2,068,000 | 2,068,000 | 1,000 | -36,000 | 154,000 |
|
Pretax Income
|
3,249,000 | 3,249,000 | 2,340,000 | 2,644,000 | 3,818,000 |
| Provision for Income Tax
|
-1,104,000 | -1,104,000 | -994,000 | -802,000 | -1,192,000 |
|
Net Income from Continuing Operations
|
2,145,000 | 2,145,000 | 1,346,000 | 1,842,000 | 2,626,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,145,000 | 2,145,000 | 1,346,000 | 1,841,000 | 2,626,000 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 0 | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
2,144,000 | 2,144,000 | 1,345,000 | 1,841,000 | 2,625,000 |
|
Net Income Available to Common Stockholders
|
2,144,000 | 2,144,000 | 1,345,000 | 1,841,000 | 2,625,000 |
|
Diluted Net Income Available to Common Stockholders
|
2,144,000 | 2,144,000 | 1,345,000 | 1,841,000 | 2,625,000 |
| Basic EPS
|
114.57 | 114.57 | 71.86 | 93.49 | 129.50 |
| Diluted EPS
|
114.53 | 114.53 | 71.85 | 92.55 | 129.42 |
|
Basic Weighted Average Shares Outstanding
|
18,720.70 | 18,720.70 | 18,715.88 | 19,691.95 | 20,270.27 |
|
Diluted Weighted Average Shares Outstanding
|
18,720.70 | 18,720.70 | 18,718.51 | 19,891.34 | 20,283.11 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,194,000 | 3,194,000 | 2,279,000 | 2,611,000 | 3,829,000 |
|
EBITDA
|
5,142,000 | 5,142,000 | 3,549,000 | 3,910,000 | 5,172,000 |
|
Normalized EBITDA
|
5,723,000 | 5,723,000 | 3,716,000 | 4,086,000 | 5,177,000 |
3/31/2023 - 1/4/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade